These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 608545)

  • 1. Complications of BCG treatment in patients bearing solid tumors.
    Serrou B; Domas J
    Dev Biol Stand; 1977 Apr 13-15; 38():515-21. PubMed ID: 608545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulomatous hepatitis in a healthy adult following BCG injection into a plantar wart.
    D'Alessandria RM; Khakoo RA
    Am J Gastroenterol; 1977 Oct; 68(4):392-5. PubMed ID: 605897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of iv administration of methanol extraction residue of Bacillus Calmette-Guérin.
    Vogl SE; Perloff M; Kaplan BH; Holland JF
    Cancer Treat Rep; 1979; 63(11-12):2039-41. PubMed ID: 393387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of BCG immunotherapy in patients with cancer.
    Sparks FC; Silverstein MJ; Hunt JS; Haskell CM; Pilch YH; Morton DL
    N Engl J Med; 1973 Oct; 289(16):827-30. PubMed ID: 4763426
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancer.
    O'Connell MJ; Ritts RE; Moertel CG; O'Fallon JR; Rubin J; Frytak S; Schutt AJ
    Cancer Clin Trials; 1981; 4(4):439-49. PubMed ID: 6459190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
    Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
    Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BCG and radiotherapy: the compatibility of 2 conservative treatments for cancer of the urinary bladder].
    Sánchez-Martín FM; Palou Redorta J; Regalado Pareja R; Rubio Briones J; Villavicencio Mavric H; Vicente Rodríguez J
    Arch Esp Urol; 1999 Sep; 52(7):749-58. PubMed ID: 10540765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of bacillus Calmette-Guérin immunotherapy.
    Lamm DL
    Urol Clin North Am; 1992 Aug; 19(3):565-72. PubMed ID: 1636240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BCG infection of the glans penis after intravesical BCG therapy].
    Michelet N; Spenatto N; Viraben R; Cuny JF; Mazet J; Trechot P; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2008; 135(6-7):479-83. PubMed ID: 18598797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of superficial tumors of the bladder with bacillus Calmette-Guérin].
    Ackermann D; Schnyder M; Bandelier D; Studer UE
    J Urol (Paris); 1986; 92(1):33-8. PubMed ID: 3722851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
    Korting HC; Strasser S; Konz B
    Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulomatous hepatitis caused by B.C.G. injection during immunotherapy of a malignant melanoma.
    Serrou B; Michel H; Dubois JB; Serre A
    Biomedicine; 1975 Jun; 23(6):236-40. PubMed ID: 764894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravesical bacillus Calmette-Guerin in the treatment of recurrent superficial bladder tumors].
    Nakano M; Iwamuro S; Fujii H; Kondoh I
    Hinyokika Kiyo; 1988 Jun; 34(6):983-6. PubMed ID: 3223463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional BCG immunotherapy of pulmonary tumors.
    Holmes EC; Ramming KP; Bein ME; Coulson WF; Callery CD
    J Thorac Cardiovasc Surg; 1979 Mar; 77(3):362-8. PubMed ID: 762979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapy.
    Hurle R; Losa A; Ranieri A; Graziotti P; Lembo A
    J Urol; 1996 Nov; 156(5):1602-5. PubMed ID: 8863547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.